Le Lézard
Classified in: Health, Science and technology

Global Body Composition Analyzers Market Report to 2027 - Size, Share & Industry Trends Analysis - ResearchAndMarkets.com


The "Global Body Composition Analyzers Market Size, Share & Industry Trends Analysis Report By Product Type, By End User (Fitness Clubs & Wellness Centers, Hospitals, and Home Users), By Regional Outlook and Forecast, 2021-2027" report has been added to ResearchAndMarkets.com's offering.

The Global Body Composition Analyzers Market size is expected to reach $494 million by 2027, rising at a market growth of 4.2% CAGR during the forecast period.

The ratio of fat and fat-free mass in the body is called body composition. Obese patients and other fitness-conscious persons require body composition analysis to test and analyze their health and fitness levels. A body composition analyzer is a gadget that gives detailed data for customized health and fitness consultations. In addition, it is also utilized to construct a workout routine based on whether a person wants to reduce weight or gain muscle. Moreover, body composition can be measured in a variety of ways, each with its own set of benefits and drawbacks.

A way of examining the body's constituent constituents, such as fat, protein, minerals, and body water, is known as body composition. Moreover, a body composition analyzer (BCA) is a device that measures the makeup of various body components. The weight, body mass index (BMI), and weight percentages from fat, muscle, bone, and water are all accurately calculated with a body composition analyzer. Further, it also aids in the investigation of cumulative differences in body structure over a given length of time.

Obesity prevalence was very high in high-income and developed countries in 2018, according to data from the website worldobesity.org, with 42.8 percent in the United States, 31.3 percent in Australia, and 21.20 percent in Belgium.

Overweight and obesity rates in OECD countries have continued to rise to 58 percent of the adult population in 2019, according to the OECD Health Policy Studies. According to the survey, more than half of the population in 34 of the 36 OECD countries was overweight, and nearly one in four persons were projected to be obese. Moreover, overweight and linked disorders is expected to shorten life expectancy by around three years throughout the OECD, EU28, and G20 countries between 2020 and 2050, according to the OECD.

Market Growth Factors:

Growing awareness about health and fitness

Some of the key trends of the market are rising obesity, overweight, and aging populations around the world, as well as increased financing from governments and worldwide healthcare institutions for preventative healthcare. In addition, growing awareness of health and fitness, metabolic disorders, and heart disease is expected to motivate people to keep a regular check on their health. In recent years, there has been an increase in government programs for a better living, various healthcare organizations such as the World Health Organization.

Growing Popularity of DEXA and ongoing studies

Dual Energy X-ray Absorptiometry Equipment (DEXA) is used to examine bone density in order to diagnose osteoporosis and assess the risk of fractures. DEXA is projected to become more commonly employed in hospitals as the prevalence of osteoporosis rises. Moreover, body composition analysis is becoming a standard aspect of patient treatment and wellness programs in many hospitals throughout the world.

Marketing Restraining Factor:

Low penetration and product recall

There are many developing countries around the world that have low penetration of advanced healthcare devices. Moreover, such countries also face problems like stagnant economic growth and under-developed healthcare infrastructure. As a result, citizens living in such countries have low awareness about advanced and latest products which include body composition analyzers. Moreover, the high cost of these products prevents many people to use them, especially from developing and under-developed countries.

Market Segments Covered in the Report:

By Product Type

By End User

By Geography

Key Market Players

For more information about this report visit https://www.researchandmarkets.com/r/uco6ln


These press releases may also interest you

at 01:00
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...



News published on and distributed by: